Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
AssigneeAventis Behring GmbH
InventorsReinhard Fleer, Alain Fournier, Jean-Dominique Guitton, Gerard Jung, Patrice Yeh
Life of this patent
Estimating the term…
Abstract
Biologically active polypeptides comprising a therapeutically active polypeptide fused to human serum albumin or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
Claims30
1-66. (canceled)
A method of treating a patient in need of interferon, comprising the step of administering a fusion protein comprising interferon and albumin or an albumin variant, wherein said fusion protein has a higher plasma stability than unfused interferon, and wherein said albumin or albumin variant is located either at the N-terminus or C-terminus of said fusion protein.
A method of treating a patient in need of interferon, comprising the step of administering a fusion protein comprising interferon and a mature form of albumin, wherein said fusion protein has a higher plasma stability than unfused interferon, and wherein said mature form of albumin is located either at the N-terminus or C-terminus of said fusion protein.
Dependencies are inferred from the claim text.